tiprankstipranks
Trending News
More News >
LB Pharmaceuticals, Inc. (LBRX)
NASDAQ:LBRX
US Market

LB Pharmaceuticals, Inc. (LBRX) Income Statement

Compare
11 Followers

LB Pharmaceuticals, Inc. Income Statement

Last quarter (Q1 2024), LB Pharmaceuticals, Inc.'s total revenue was $0.00. In Q1, LB Pharmaceuticals, Inc.'s net income was $-16.15M. See LB Pharmaceuticals, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22
Total Revenue
$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 64.83M$ 11.38M$ 2.81M
Depreciation and Amortization
$ 91.00K$ 4.00K$ 2.00K
EBITDA
$ -63.01M$ -1.45M$ -12.19M
Operating Income
$ -64.83M$ -11.38M$ -2.81M
Other Income/Expenses
$ 1.73M$ 5.10M$ -11.54M
Pretax Income
$ -63.10M$ -6.27M$ -14.35M
Net Income
$ -63.10M$ -6.28M$ -14.35M
Per Share Metrics
Basic EPS
$ -17.83$ -1.77$ -4.05
Diluted EPS
$ -17.83$ -1.77$ -4.05
Weighted Average Shares Outstanding
3.54M 3.54M 3.54M
Weighted Average Shares Outstanding (Diluted)
3.54M 3.54M 3.54M
Currency in USD

LB Pharmaceuticals, Inc. Earnings and Revenue History